Top Page
Pangea Natural Food, Inc.
(PNGA)
Pangea Natural Food, Inc. (PNGA) vs. iShares MSCI Canada ETF (EWC)
Pangea Natural Food, Inc. Business Overview & Revenue Model
Pangea Natural Food, Inc. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.00K | 12.20K | 285.59K | 580.99K | 68.50K |
| Gross Profit | 7.46K | 6.91K | -32.79K | 40.97K | -67.25K |
| EBITDA | -1.54M | -917.21K | -1.64M | -855.30K | -172.28K |
| Net Income | -1.66M | -1.03M | -1.66M | -1.13M | -173.19K |
Balance Sheet | |||||
| Total Assets | 4.39M | 182.29K | 191.72K | 620.34K | 1.34M |
| Cash, Cash Equivalents and Short-Term Investments | 1.82M | 140.09K | 51.64K | 75.95K | 807.57K |
| Total Debt | 0.00 | 17.83K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 300.33K | 732.74K | 330.00K | 408.57K | 116.82K |
| Stockholders Equity | 4.09M | -550.45K | -138.28K | 211.76K | 1.23M |
Cash Flow | |||||
| Free Cash Flow | -973.54K | -439.41K | -980.68K | -725.80K | -590.75K |
| Operating Cash Flow | -973.54K | -439.41K | -980.68K | -718.60K | -529.76K |
| Investing Cash Flow | -672.62K | 0.00 | 0.00 | -7.20K | -60.98K |
| Financing Cash Flow | 3.46M | 527.86K | 956.37K | -1.32K | 1.40M |
Pangea Natural Food, Inc. Technical Analysis
Pangea Natural Food, Inc. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | C$4.33M | -0.65 | -70.53% | ― | -41.18% | 17.65% | |
45 Neutral | C$1.48M | -1.56 | ― | ― | -3.76% | 86.34% | |
44 Neutral | C$5.24M | -0.34 | -517.87% | ― | -25.08% | 65.57% | |
41 Neutral | C$30.58M | -0.14 | -190.55% | ― | ― | -126.28% | |
27 Underperform | C$8.91M | -1.63 | -86.40% | ― | -49.04% | 15.66% |
Pangea Natural Food, Inc. Corporate Events
Amino Innovations, a subsidiary of Pangea Wellness Inc., has appointed Dave Asprey, Jim Gunning, and Travis Rosbach as strategic advisors to bolster its brand growth and market expansion. These appointments aim to enhance the company’s strategic leadership as it grows across retail, wholesale, and direct-to-consumer channels, with a focus on new delivery systems and clinical partnerships. The advisors bring significant experience in biohacking, brand development, and consumer product innovation, which is expected to accelerate Amino Innovations’ growth and strengthen its position in the human performance and peptide-based wellness industry. Additionally, Pangea Wellness has granted 2,500,000 stock options to certain officers, directors, employees, and consultants as part of its long-term incentive plan.
Amino Innovations, a subsidiary of Pangea Wellness Inc., has launched a U.S. wholesale and B2B distribution program to expand access to its non-injectable peptide-based wellness products. This initiative introduces a comprehensive distribution model, providing clinics, wellness centers, and performance facilities with alternatives to traditional injectable therapies through products like oral capsules and topical creams. The program aims to enhance accessibility and customer experience while offering new revenue streams for partners, positioning Amino Innovations as a leader in the peptide wellness industry.
Pangea Natural Foods Inc. has filed amended and restated interim financial statements and management’s discussion and analysis for specific periods in 2025 following a review by the British Columbia Securities Commission. This amendment includes additional disclosures related to the company’s accounting policy for its acquisition of Amino Innovations and an assessment of impairment indicators for intangible assets and goodwill. These updates are significant as they provide stakeholders with a clearer understanding of the company’s financial health and strategic decisions, potentially impacting investor confidence and market positioning.
Pangea Natural Foods Inc. has announced a name change to Pangea Wellness Inc., effective November 19, 2025. The company’s shares will continue to trade under the same symbol on the CSE, with no change to its share capital. This rebranding reflects a broader focus on wellness products, potentially enhancing its market positioning and stakeholder engagement.
Pangea Natural Foods Inc.’s subsidiary, Amino Innovations, has partnered with University of Alberta scientists to advance non-injectable peptide delivery systems for consumer wellness. This collaboration aims to enhance peptide absorption and stability, leveraging natural enhancers, and is expected to bolster Amino Innovations’ intellectual property and regulatory credibility, potentially accelerating product development in the nutraceutical and cosmeceutical markets.
Pangea Natural Foods Inc., through its subsidiary Amino Innovations, has developed a next-generation peptide patch platform that simplifies peptide delivery without the need for needles. This innovative technology, which uses bio-dissolving lattice technology for efficient absorption, aims to redefine everyday wellness and expand the market for peptide therapies. The patches are designed for convenience and effectiveness, targeting active individuals and those seeking advanced recovery and wellness support. The initial product launch includes formulations for recovery and immune optimization, marking a significant milestone in the company’s expansion into the health and wellness sector.
Pangea Natural Foods Inc. has engaged Emerging Markets Consulting, LLC (EMC) to provide investor relations and communication services for a six-month term at a fee of USD $150,000. This collaboration aims to enhance Pangea’s market presence and investor engagement through EMC’s expertise in design, development, and dissemination services, potentially strengthening Pangea’s positioning in the wellness and clean-label food industry.
Amino Innovations, a subsidiary of Pangea Natural Foods Inc., is expanding its market presence by participating in prominent health and longevity events, including the MoreLife Biohacking Summit and the Healthspan Summit. These events provided a platform for Amino Innovations to showcase its non-injectable peptide products, generating interest from health professionals and wellness enthusiasts. The company’s involvement in these summits positions it as an emerging innovator in the peptide therapy market, with plans to launch a peptide patch that could redefine at-home peptide therapy.
Pangea Natural Foods Inc. has announced the launch of its peptide products and a needle-less delivery system through its subsidiary, Amino Innovations. This move follows the acquisition of Amino Innovations and positions Pangea in the growing peptide therapeutics market, which is projected to reach $260.25 billion by 2030. The company has introduced an eCommerce platform to facilitate direct-to-consumer sales and has initiated marketing campaigns to boost product visibility. Additionally, Pangea is advancing the development of novel peptide delivery systems and maintains high manufacturing standards at its U.S.-based facilities. The launch of a new website and corporate materials aims to align with the company’s mission and appeal to investors.